IBD barriers across the continents - East Asia

Joyce Wing Yan Mak; Agnes Hiu Yan Ho; Siew Chien Ng

doi:10.1177/17562848231212089

IBD barriers across the continents - East Asia

Therap Adv Gastroenterol. 2023 Nov 22:16:17562848231212089. doi: 10.1177/17562848231212089. eCollection 2023.

Authors

Joyce Wing Yan Mak¹, Agnes Hiu Yan Ho¹, Siew Chien Ng²

Affiliations

¹ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
² Department of Medicine and Therapeutics, Microbiota I-Center (MagIC), Center for Gut Microbiota Research, The Chinese University of Hong Kong, Shatin, Hong Kong.

Abstract

Inflammatory bowel diseases (IBDs) are chronic illnesses with significant morbidities and impact on patients' quality of life. There has been a rapid increase in the incidence of IBD in East Asia in recent decades. However, there is a huge unmet need in the diagnosis and management of IBD in this region. With the increasing awareness of IBD in East Asia and a persistently high rate of tuberculosis in this region, this poses a significant challenge in the diagnosis and management of IBD. In this review, we will explore the barriers to the diagnosis and management of IBD in the East Asia, hoping to provide an insight on how to improve the healthcare system in the management of this complex disease.

Keywords: Crohn’s disease; barriers; inflammatory bowel disease; ulcerative colitis.

Publication types

Review